Contrast-induced nephropathy: prevention and management of high-risk patients
Caixeta, A.; Nikolsky, E.; Mehran, R.
Indian Heart Journal 60(6): 524-531
2008
ISSN/ISBN: 0019-4832 PMID: 19276490 Document Number: 617419
Document emailed within 1 workday
Related Documents
Nijssen, E.C.; Rennenberg, R.J.; Nelemans, P.J.; Essers, B.A.; Janssen, M.M.; Vermeeren, M.A.; van Ommen, V.; Wildberger, J.E. 2018: Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial Nederlands Tijdschrift Voor Geneeskunde 161: D1734Calabrò, P.; Bianchi, R.; Caprile, M.; Sordelli, C.; Cappelli Bigazzi, M.; Palmieri, R.; Gigantino, G.; Limongelli, G.; Capozzi, G.; Cuomo, S.; Calabrò, R. 2010: Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography Minerva Cardioangiologica 58(1): 35-40
Tamai, N.; Ito, S.; Nakasuka, K.; Morimoto, K.; Miyata, K.; Inomata, M.; Yoshida, T.; Suzuki, S.; Murakami, Y.; Sato, K. 2012: Sodium bicarbonate for the prevention of contrast-induced nephropathy: the efficacy of high concentration solution Journal of Invasive Cardiology 24(9): 439-442
Zhao, Y.-y.; Liu, D.-w.; Wang, J.-s.; Ouyang, J.; Zhang, W.-z.; Zhang, W.-j.; Meng, J.-q.; Tang, J.-m. 2012: Risk factors of contrast-induced nephropathy in patients after coronary artery intervention Zhonghua Yi Xue Za Zhi 92(22): 1547-1549
Hoshino, A.; Enomoto, S.; Kawahito, H.; Kurata, H.; Nakahara, Y.; Nakamura, T. 2007: Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents Journal of Cardiology 50(2): 119-126
Chong, E.; Shen, L.; Poh, K.K.; Tan, H.C. 2012: Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention Singapore Medical Journal 53(3): 164-169
Ilkhanoff, L.; Carver, J. 2005: Contrast-induced nephropathy and cardiac catheterization: evidence in support of using the iso-osmolar contrast agent iodixanol in patients with renal dysfunction Journal of Invasive Cardiology 17(4): 216-217
Moos, S.I.; Stoker, J.; Beenen, L.F.M.; Flobbe, K.; Bipat, S. 2013: The prevention of contrast-induced nephropathy in Dutch hospitals Netherlands Journal of Medicine 71(2): 97-103
Kooiman, J.; van der Molen, A.J.; Cannegieter, S.C.; Rabelink, T.J. 2013: Prevention of contrast-induced nephropathy: time for nuance and a new guideline Nederlands Tijdschrift Voor Geneeskunde 157(12): A5475
Reddan, D.; Laville, M.; Garovic, V.D. 2009: Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? Journal of Nephrology 22(3): 333-351
Möckel, M.; Bahr, F.; Leuner, C.; Kuhn, H.; Dietz, R. 2002: Recommendations for prevention of roentgen contrast medium-induced nephropathy Zeitschrift für Kardiologie 91(9): 719-726
Nicholas, B.A.; Vricella, G.J.; Smith, M.; Passalacqua, M.; Gulani, V.; Ponsky, L.E. 2012: Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk Canadian Journal of Urology 19(1): 6074-6080
Gomes, V.O.; Blaya, P.; Poli de Figueiredo, C.E.; Manfroi, W.; Caramori, P. 2003: Contrast-media induced nephropathy in patients undergoing coronary angiography Journal of Invasive Cardiology 15(6): 304-310
Gundlach, P.J.; van Beek-Peeters, J.A.M.J.; Ruissen, J.; Verberk-Jonkers, I.J.A.M. 2015: Contrast-induced nephropathy and mortality after contrast-based investigation Nederlands Tijdschrift Voor Geneeskunde 159: A8501
De Mauri, A. 2009: Contrast-induced nephropathy: a contrast without a winner Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(2): 141
Liu, Y.; Liu, Y.; Chen, J.; Chen, J.; Chen, S.; Ye, P.; Tan, N.; Li, H. 2014: The correlation of anemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention Zhonghua Nei Ke Za Zhi 53(3): 168-173
Azzalini, L.; Laricchia, A.; Regazzoli, D.; Mitomo, S.; Hachinohe, D.; Bellini, B.; Demir, O.M.; Poletti, E.; Maccagni, D.; Colombo, A. 2019: Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients with Severe Chronic Kidney Disease Journal of Invasive Cardiology 31(6): 176-182
Taniguchi, Y.; Terada, Y. 2016: Contrast-induced nephropathy Nihon Jinzo Gakkai shi 58(7): 1079-1082
Kabalan, S.N.; El-Imad, B.G.; Geara, A.S. 2007: Contrast-induced nephropathy Le Journal Medical Libanais. Lebanese Medical Journal 55(1): 29-38
Gurdogan, M.; Ari, H. 2019: The effect of thyroid functions on contrast-induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention Jpma. Journal of the Pakistan Medical Association 69(10): 1453-1458